When ACAD took that huge dump it was for a good reason. This recent short report is weak, but well orchestrated together with the Zack's junk. The timing was perfect. Hard to beat the big hedge funds when they want blood. But I am thinking it will be short lived, hopefully we see the beginning of a reversal pattern by the end of the week. It takes brass nuts to hold and not go with the flow.
Will pick up cheap shares once the investors figure it out.
I have read though their report, first their source of info is highly questionable...they copied & pasted a picture someone gave them. They do not reveal the source. And buy the way many of those 120 mg results are on the ITCI web site under presentation and events. They had to post the entire report in RED to " sound the alarm !!! They question how come 60mg works and 120mg doesn't....they call it a "key omission" these guys are certainly not scientist, they have no clue what a simple dose response curve is- and hope you don't either. If its such a key omission how did it end up on a poster at a medical conference? Dah. Their words: " Bulls believe ITI007 would have to be the one antipsychotic where a little bit of drug helps the patient but increasing the dose is no better than taking a placebo. As we like to say often at Little Bear C’mon ! "" (What amateurs). Then at the end they say " In short, even if ITI-007 does get FDA approval it will face a cluttered price -sensitive market with far better choices both banded and generic including a once monthly injectable version of Abilify "" This is basically an admission that the drug will probably get approved. But what they are excellent at is putting big money into their short position. They will be buying your shares if you let them.
...."we were finally able to track down this information from someone with a digital copy of the poster presentation." Oh is that a new way to do research? Copy and paste from a source you don't reveal. This whole thing is a made up pile of BuII.
Disclosure : At the time of publication of this report, Little Bear and its’ affiliates hold short positions in Intra-Cellular Therapies, Inc. common stock.
Oh, you come on the boards and warn us of impeding doom and save us from our bad investments...kinda like a super hero.
Everyone stop calling ACAD a "Company"-a Spader Decree !!!
Spader has spoken and has placed an authoritative order. So all you " clueless" folks who were under the impression that ACAD was a company MUST OBEY !!!!
SPADER is the Great Carnac ! So be on your best behavior and do not refer to ACAD as a " company " or face the wrath of the Kwisatz Haderach ....it is not a company, NO NO NO !!! Spader has spoken. He has put down his last 3 Therapy Pets so think what he might do to you.
"" the_spader_3000 • 5 hours ago Flag
..... and the good folks here, most of whom are clueless would be better served ""
Seems like every time you open your mouth you stick your foot in it. So calling everyone clueless took all of your "critical thinking skill "? Do something you probably never did in your life, admit your were wrong, just upset or what ever and APOLOGIZE to the " good folks " on the message board. Be a man for once in your life.
Now spader...You are obsessed with me I understand....remember you put me on IGNORE because I called you out for what you are....do we need to revisit that? So try to control your emotions. I didn't call you any names did I. You are welcome to your opinion, no matter how good or bad...you come up with some good points, but "ACAD is not a company", ROTFLMAO..... So please take your meds and do your deep breathing exercises or I will have to B-$Iap you like before...You don't really want to go there do you? Go out for a walk, the world is a beautiful place.
What it is , is that the optimal dose of ITI007 is 60mg. I suspect the receptor systems targeted are fully saturated at 60 mg, 120mg is not helpful and most likely will not help much more than 60 mg but will increase the side effect profile or just cost more and will not show better effects than 60 mg. This is a simple dose response curve. Just like 21% atmospheric oxygen is all you need to keep your blood O2 saturation over 90%, a lot more will get you into trouble. biotrader will cover on Monday.
So reading between the lines, you shorted at $33.40 and now you are screwed. Buzzzzzzzzzzzzz Try Again.
Wondering if this is Davis trying to cover his bases. Not out just yet, but perhaps handed his hat.